title: Valproate and HDAC inhibition: a new epigenetic strategy to mitigate phenotypic severity in ALS?
authors.affiliation: Department of Neuroscience, University of Milano-Bicocca, Monza, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Tremolizzo
authors.forename: V
authors.initials: V
authors.lastname: Rodriguez-Menendez
authors.forename: G
authors.initials: G
authors.lastname: Sala
authors.forename: J C
authors.initials: JC
authors.lastname: Di Francesco
authors.forename: C
authors.initials: C
authors.lastname: Ferrarese
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000201:enzymology; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D010641:Phenotype; D014635:Valproic Acid / Q000627:therapeutic use*
chemical_list: D056572:Histone Deacetylase Inhibitors; D014635:Valproic Acid